9926:HKG
Akeso Inc
HK$91.30
arrow_upward
+0.94%(+0.85) 1D
Oct 16, 4:08:14 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$92.15
High
HK$95.30
Low
HK$90.15
Mkt. cap
84.10B
Avg. vol.
10.45M
Volume
11.09M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
Open
HK$92.15
High
HK$95.30
Low
HK$90.15
Mkt. cap
84.10B
Avg. vol.
10.45M
Volume
11.09M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
News stories
From web sources and news partners
Yahoo Finance
·
14 hours ago
Will Phase III Colon Cancer Trial Change Akeso Stock Narrative
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com